2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1467598839 M.D.
Verify on CMS →

MICHELLE WIDLITZ, M.D.

Addiction Medicine (Psychiatry & Neurology) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
488
Medicare Part D claims · 67 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$30.12
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MICHELLE WIDLITZ, M.D. filed 488 Medicare Part D claims in 2023 as a Addiction Medicine (Psychiatry & Neurology) Physician in NEW YORK, New York, prescribing 97% generic.

488
Part D claims, 2023
97%
generic prescribing
$30.12
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHELLE WIDLITZ, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

488 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MICHELLE WIDLITZ, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHELLE WIDLITZ, M.D.?

Quality data not reported

NPI registry status

Active

Issued 01/30/2007

NPI 1467598839

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

488 52% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

Specialty distribution in New York

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among New York providers

New York providers

Addiction Medicine (Psychiatry & Neurology) Physician share within New York

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHELLE WIDLITZ, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at 211 E 43RD ST, NEW YORK, NY, 10017, with a listed phone of (212) 490-1348. NPI 1467598839 was issued on 01/30/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WIDLITZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 488 prescription claims written by this provider, covering 67 Medicare beneficiaries and totaling roughly $70K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

211 E 43RD ST
NEW YORK, NY 10017

Provider Details

NPI 1467598839
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Credentials M.D.
Gender Female
NPI Issued 01/30/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHELLE WIDLITZ, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$30

Largest payer

E.R. Squibb & Sons, L.L.C.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MICHELLE WIDLITZ, M.D.. To verify MICHELLE WIDLITZ, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHELLE WIDLITZ, M.D. — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 488 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

488
Total Claims
$70K
Total Drug Cost
67
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
545
Total Day Supply
15,858
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$58K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
62.1 years
Avg HCC Risk Score
1.30
Gender Split
55% female / 45% male
Age Distribution
<65: 29, 65-74: 29, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MICHELLE WIDLITZ, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trazodone Hcl
42
Mirtazapine
41
Sertraline Hcl
41
Clonazepam
40
Benztropine Mesylate
34
Olanzapine
23
Venlafaxine Hcl Er
Venlafaxine Hcl
22
Divalproex Sodium
21
Buspirone Hcl
20
Quetiapine Fumarate
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How MICHELLE WIDLITZ, M.D. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

MICHELLE WIDLITZ, M.D.'s 488 claims are below the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as WIDLITZ.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHELLE WIDLITZ, M.D.'s specialty?
MICHELLE WIDLITZ, M.D. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does MICHELLE WIDLITZ, M.D. prescribe under Medicare Part D?
In 2023, MICHELLE WIDLITZ, M.D. wrote 488 Medicare Part D claims totaling $70K in drug costs for 67 beneficiaries.
Where is MICHELLE WIDLITZ, M.D. located?
MICHELLE WIDLITZ, M.D. is located at 211 E 43RD ST, NEW YORK, NY, 10017. Phone: (212) 490-1348.
What is MICHELLE WIDLITZ, M.D.'s NPI number?
MICHELLE WIDLITZ, M.D.'s National Provider Identifier (NPI) is 1467598839, issued on 01/30/2007.
Does MICHELLE WIDLITZ, M.D. prescribe more brand-name or generic drugs?
MICHELLE WIDLITZ, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $58K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does MICHELLE WIDLITZ, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MICHELLE WIDLITZ, M.D.'s most frequently prescribed drugs include Trazodone Hcl, Mirtazapine, Sertraline Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHELLE WIDLITZ, M.D. accept Medicare?
MICHELLE WIDLITZ, M.D. appears in CMS Medicare data with 488 Part D claims and 67 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHELLE WIDLITZ, M.D.'s credentials?
MICHELLE WIDLITZ, M.D.'s NPI is 1467598839 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology